Altimmune
ALT
ALT
122 hedge funds and large institutions have $640M invested in Altimmune in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 110 → 122 (+12)
10% more ownership
Funds ownership: 92.33% → 102.32% (+10%)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
122
Holding in Top 10
4
Calls
$49.7M
Puts
$19.7M
Top Buyers
| 1 | +$105M | |
| 2 | +$41.7M | |
| 3 | +$10.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$10.6M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$9.58M |
Top Sellers
| 1 | -$13M | |
| 2 | -$12.8M | |
| 3 | -$11.2M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$10.1M |
| 5 |
Morgan Stanley
New York
|
-$9.99M |